NEW YORK (GenomeWeb News) — Biosite yesterday received another set of revised commitment letters from Inverness Medical Innovations’ proposed financing sources related to Inverness’ offer to buy the diagnostics company for $90 a share, the company said today.
 
Inverness initially sent Biosite the commitment letters on April 4, then submitted a revised set of letters earlier this week.   

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.